11/13
04:05 pm
aeon
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
High
Report
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/1
08:01 am
aeon
AEON Biopharma, Inc. (NASDAQ: AEON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
AEON Biopharma, Inc. (NASDAQ: AEON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
9/30
08:00 am
aeon
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting
High
Report
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting